Business Wire

Smart Lidar Network Set to Unlock Missing Layer in Surveillance Technology, Live at GSX 2019

Share

A network of laser powered smart sensors that can automatically link with other types of sensors and activate CCTV cameras to provide multi-dimensional surveillance will be launched at Global Security Exchange (GSX) in Chicago next week.

Cepton Technologies’ Helius™ system utilizes the power and accuracy of laser combined with smart AI driven detection and tracking technologies to build a detailed image of activity in a given area, regardless of lighting conditions.

Aimed at seamless integration into existing security systems, Helius is a smart lidar network utilizing edge computing to offer real-time detection, tracking and classification. The Helius system combines full 3D data, dimension, location and velocity, from multiple smart sensors in different locations to allow for comprehensive coverage and real-time monitoring. Users can create and manage event zones and triggers to activate alarms or other types of sensors for further verification, when potential threats are detected.

Ahead of appearing at the GSX between September 8-12, Cepton’s head of product Jerone Floor said: “Being able to link our smart sensors together in a Helius network provides an unprecedented level of coverage to critical areas.

“Helius adds an additional layer to an existing security system, filling the medium-range gap and augmenting it with the capability to classify objects including human, small animals and vehicles, as well as behaviours such as crawling, crouching and running.”

When operating in tandem, the sensors can be used to analyse the same area from multiple different perspectives, eliminating blind spots and ensuring maximum coverage.

“With our low power requirements and high resolution 3D imaging regardless of lighting conditions, the Helius system creates a new era of multi-dimensional security fit for use in almost any environment,” Jerone introduced.

The Helius system consists of a network of smart lidar units called Vista-Edge™, which combines a lidar sensor with a powerful micro-computer in a single package. Powered by Cepton’s patented Micro-Motion Technology (MMT™) system, the Vista-Edge is rotation free and already front facing, so it can fit into a standard security camera housing.

The micro-computer processes the information directly at the ‘edge’* so it highlights only potential threats. Because data processing is done inside the unit, data transmission is kept to a minimum, using only a few kilobytes where video would require several megabytes of storage.

This means each sensor can be deployed using only basic cellular SIM cards – and with minimal power requirements, wireless installation is possible.

And because the Helius perception and networking software is browser-based, you can operate the system on mobiles and tablets to maximize user simplicity.

Neil Huntingdon, Cepton’s VP of Business Development, said: “In the past, the prospect of truly comprehensive surveillance coverage has been limited to deploying multiple cameras across a location, and having someone present to monitor each camera. That’s expensive to deploy and expensive to run, even just in having the data capacity to transmit all that video footage.

“The Helius system delivers absolute coverage with smart monitoring system that gives potential threats no hiding place. This is next-generation security for the connected era.”

Designed with user simplicity in mind, the Helius system can operate over WiFi, cellular networks or Ethernet, and can even be used to monitor traffic – and can identify when packages are left or thrown over fences or walls.

Jerone added: “The unerring accuracy of our system means we zero in on potential threats with, literally, a laser-focus. It can then be used to trigger accompanying security systems, such as cameras, to capture more detailed footage of the perceived threat, or to raise the alarm with security personnel.

“Helius offers a step change in surveillance and security response measures, minimising false positives and false negatives, reducing threat and delivering a drastic improvement in security confidence.”

Formerly the ASIS International Annual Seminar and Exhibits, Global Security Exchange (GSX) is the most relevant and pioneering security event that unites the full spectrum of the industry. Cyber, operational, and physical security professionals from across the private and public sectors, allied organizations and partners, and the industry’s leading solution providers come to GSX for the most comprehensive security education and innovative technology in the world.

Held at McCormack Place, Chicago, Exhibit Hall A, Cepton Technologies will be at stand 1894, next to the bistro. To schedule a meeting onsite, please email: media@cepton.com

*Edge processing

Edge processing refers to the execution of aggregation, data manipulation, bandwidth reduction and other logic directly on an IoT sensor or device. The more work the device can do to prepare the data for the cloud, the less work the cloud needs to do.

About Vista-Edge

Vista-Edge is a smart sensor unit which combines Cepton’s high performance lidar sensor with a powerful edge computing device. Pre-installed with the Helius perception and network software, it is designed to enable Cepton’s eco-system partners to integrate and develop solutions tailored for specific markets. For example, Security, Transport Infrastructure and Retail integrators can now augment traditional solutions with state-of-the-art 3D lidar-based tracking.

Vista-Edge is powered by NVIDIA’s AI computing platform, the Jetson TX2, and functions with Cepton’s portfolio of MMT lidar sensors which provide high resolution and long-range 3D imaging.

Vista-Edge is a true plug and play device. Out-of-the-box, the system takes only a few minutes to set up. Software included and pre-installed in the package is the Cepton SDK, CeptonViewer and the Perception Server. The hardware features compact, lightweight design and has ports for 1Gb Ethernet, HDMI, USB 3.0 and USB 2.0 connections, and can function on IoT and Wi-Fi networks.

About Cepton Technologies, Inc.

Cepton Technologies, Inc. is a 3D sensing solutions provider shipping next-generation lidar-based products for the security, smart infrastructure, transport and retail markets. For more information, visit http://www.cepton.com/.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Dyan Owen: + 44 141 343 3254 / +44 7738 086 818 dowen@webershandwick.com
Steven Flanagan: +44 141 343 3250 / sflanagan@webershandwick.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Ant International Wins Champion of NeurIPS Competition of Fairness in AI Face Detection8.12.2025 05:37:00 EET | Press release

Ant International, a leading global digital payment, digitisation, and financial technology provider, has won first place at the NeurIPS Competition of Fairness in AI Face Detection. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207210856/en/ Ant International’s solution takes top spot at the NeurIPS Competition of Fairness in AI Face Detection, emerging first among over 2,100 submissions from 162 teams globally. AI Fairness enhances Financial Security Studies by the National Institute of Standards and Technology (NIST) show that many commercial facial recognition algorithms have significantly higher error rates for women and people of colour largely due to underrepresentation in datasets AI algorithms are trained on. Biased algorithms lead to unfair denials of service and create security vulnerabilities. The competition at the Conference on Neural Information Processing Systems, among the world’s most prestigious AI con

Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies8.12.2025 01:00:00 EET | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data on sonrotoclax, a next-generation investigational BCL2 inhibitor, demonstrating meaningful clinical benefit as monotherapy and in combination across B-cell malignancies. These data were featured at the 67th American Society of Hematology (ASH) Annual Meeting & Exposition in Orlando, Florida. The five presentations highlight durable responses in heavily pretreated patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL) and additional studies showing deep, rapid, and sustained undetectable minimal residual disease (uMRD) rates with sonrotoclax-based combinations in patients with treatment-naive chronic lymphocytic leukemia (CLL), highlighting the foundational potential of this medicine. “The data we’re presenting at ASH 2025 are redefining what physicians can expect from sonrotoclax as a next-generation BCL2 inhibitor,” said Amit Agarwal, M.D., Ph.D., Chief Medical

Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 18:00:00 EET | Press release

AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th

CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 14:00:00 EET | Press release

Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships Powering the Summit CoMotion GLOBAL 2025 is hosted by the Saudi Conventions & Exhibitions General Authority (SCEGA), supported by key Saudi

Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67 th American Society of Hematology (ASH) Annual Meeting6.12.2025 16:30:00 EET | Press release

Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which Ono obtained exclusive global rights for the development and commercialization of sapablursen. “In the treatment of PV, phlebotomy and cytoreductive therapy are performed as treatments for preventing thrombosis. Phlebotomy is the most common treatment for PV, in which blood

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye